Advertisement
Screener

LARIMAR THERAPEUTICS, INC. (LRMR) Increase (Decrease) in Other Noncurrent Assets

LARIMAR THERAPEUTICS, INC. Increase (Decrease) in Other Noncurrent Assets

LARIMAR THERAPEUTICS, INC. (LRMR) reported Increase (Decrease) in Other Noncurrent Assets of -$43.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInOtherNoncurrentAssets · last filed 2026-08-04

  • LARIMAR THERAPEUTICS, INC. increase (decrease) in other noncurrent assets for the quarter ending 2026-06-30 was -$24.00K.
  • LARIMAR THERAPEUTICS, INC. increase (decrease) in other noncurrent assets for the quarter ending 2026-03-31 was -$19.00K.
  • LARIMAR THERAPEUTICS, INC. increase (decrease) in other noncurrent assets for the quarter ending 2025-12-31 was -$19.00K.
  • LARIMAR THERAPEUTICS, INC. increase (decrease) in other noncurrent assets for the quarter ending 2025-09-30 was -$19.00K.
  • LARIMAR THERAPEUTICS, INC. increase (decrease) in other noncurrent assets for fiscal 2025 was -$73.00K.
  • LARIMAR THERAPEUTICS, INC. increase (decrease) in other noncurrent assets for fiscal 2024 was -$63.00K, a 400.00% decline from fiscal 2023.
  • LARIMAR THERAPEUTICS, INC. increase (decrease) in other noncurrent assets for fiscal 2023 was $21.00K.
  • LARIMAR THERAPEUTICS, INC. increase (decrease) in other noncurrent assets for fiscal 2022 was -$31.00K, a 112.40% decline from fiscal 2021.
Period endIncrease (Decrease) in Other Noncurrent Assets 3 monthIncrease (Decrease) in Other Noncurrent Assets 6 monthIncrease (Decrease) in Other Noncurrent Assets 6 month as first filedIncrease (Decrease) in Other Noncurrent Assets 9 monthIncrease (Decrease) in Other Noncurrent Assets 9 month as first filedIncrease (Decrease) in Other Noncurrent Assets 12 monthIncrease (Decrease) in Other Noncurrent Assets 12 month as first filed
2026-06-30-$24.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04
-$43.00K
10-Q · filed 2026-08-04
-$62.00K
derived: sum of 3 quarters · filed 2026-08-04
-$81.00K
derived: sum of 4 quarters · filed 2026-08-04
2026-03-31-$19.00K
10-Q · filed 2026-05-14
-$38.00K
derived: sum of 2 quarters · filed 2026-05-14
-$57.00K
derived: sum of 3 quarters · filed 2026-05-14
-$78.00K
derived: sum of 4 quarters · filed 2026-08-04
2025-12-31-$19.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19
-$38.00K
derived: sum of 2 quarters · filed 2026-03-19
-$59.00K
derived: sum of 3 quarters · filed 2026-08-04
-$73.00K
10-K · filed 2026-03-19
2025-09-30-$19.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05
-$40.00K
derived: sum of 2 quarters · filed 2026-08-04
-$54.00K
10-Q · filed 2025-11-05
-$79.00K
derived: sum of 4 quarters · filed 2026-08-04
2025-06-30-$21.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04
-$35.00K
10-Q · filed 2026-08-04
-$60.00K
derived: sum of 3 quarters · filed 2026-08-04
-$75.00K
derived: sum of 4 quarters · filed 2026-08-04
2025-03-31-$14.00K
10-Q · filed 2026-05-14
-$39.00K
derived: sum of 2 quarters · filed 2026-05-14
-$54.00K
derived: sum of 3 quarters · filed 2026-05-14
-$96.00K
derived: sum of 4 quarters · filed 2026-05-14
2024-12-31-$25.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-19
-$40.00K
derived: sum of 2 quarters · filed 2026-03-19
-$82.00K
derived: sum of 3 quarters · filed 2026-03-19
-$63.00K
10-K · filed 2026-03-19
2024-09-30-$15.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05
-$57.00K
derived: sum of 2 quarters · filed 2025-11-05
-$38.00K
10-Q · filed 2025-11-05
-$13.00K
derived: sum of 4 quarters · filed 2025-11-05
2024-06-30-$42.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14
-$23.00K
10-Q · filed 2025-08-14
$2.00K
derived: sum of 3 quarters · filed 2025-08-14
-$8.00K
derived: sum of 4 quarters · filed 2025-08-14
2024-03-31$19.00K
10-Q · filed 2025-04-30
$44.00K
derived: sum of 2 quarters · filed 2025-04-30
$34.00K
derived: sum of 3 quarters · filed 2025-04-30
$46.00K
derived: sum of 4 quarters · filed 2025-04-30
2023-12-31$25.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-24
$15.00K
derived: sum of 2 quarters · filed 2025-03-24
$27.00K
derived: sum of 3 quarters · filed 2025-03-24
$21.00K
10-K · filed 2025-03-24
2023-09-30-$10.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-30
$2.00K
derived: sum of 2 quarters · filed 2024-10-30
-$4.00K
10-Q · filed 2024-10-30
-$9.00K
derived: sum of 4 quarters · filed 2024-10-30
2023-06-30$12.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08
$6.00K
10-Q · filed 2024-08-08
$1.00K
derived: sum of 3 quarters · filed 2024-08-08
-$5.00K
derived: sum of 4 quarters · filed 2024-08-08
2023-03-31-$6.00K
10-Q · filed 2024-05-09
-$11.00K
derived: sum of 2 quarters · filed 2024-05-09
-$17.00K
derived: sum of 3 quarters · filed 2024-05-09
-$36.00K
derived: sum of 4 quarters · filed 2024-05-09
2022-12-31-$5.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14
-$11.00K
derived: sum of 2 quarters · filed 2024-03-14
-$30.00K
derived: sum of 3 quarters · filed 2024-03-14
-$31.00K
10-K · filed 2024-03-14
2022-09-30-$6.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-14
-$25.00K
derived: sum of 2 quarters · filed 2023-11-14
-$26.00K
10-Q · filed 2023-11-14
-$28.00K
derived: sum of 4 quarters · filed 2023-11-14
2022-06-30-$19.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-10
-$20.00K
10-Q · filed 2023-08-10
-$22.00K
derived: sum of 3 quarters · filed 2023-08-10
-$23.00K
derived: sum of 4 quarters · filed 2023-08-10
2022-03-31-$1.00K
10-Q · filed 2023-05-15
-$3.00K
derived: sum of 2 quarters · filed 2023-05-15
-$4.00K
derived: sum of 3 quarters · filed 2023-05-15
-$82.00K
derived: sum of 4 quarters · filed 2023-05-15
2021-12-31-$2.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14
-$3.00K
derived: sum of 2 quarters · filed 2023-03-14
-$81.00K
derived: sum of 3 quarters · filed 2023-03-14
$250.00K
10-K · filed 2023-03-14
2021-09-30-$1.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10
-$79.00K
derived: sum of 2 quarters · filed 2022-11-10
$252.00K
10-Q · filed 2022-11-10
$593.00K
derived: sum of 4 quarters · filed 2022-11-10
2021-06-30-$78.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11
$253.00K
10-Q · filed 2022-08-11
$594.00K
derived: sum of 3 quarters · filed 2022-08-11
$592.00K
derived: sum of 4 quarters · filed 2022-08-11
2021-03-31$331.00K
10-Q · filed 2022-05-12
$672.00K
derived: sum of 2 quarters · filed 2022-05-12
$670.00K
derived: sum of 3 quarters · filed 2022-05-12
$648.00K
derived: sum of 4 quarters · filed 2022-05-12
2020-12-31$341.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-25
$339.00K
derived: sum of 2 quarters · filed 2022-03-25
$317.00K
derived: sum of 3 quarters · filed 2022-03-25
$318.00K
10-K · filed 2022-03-25
2020-09-30-$2.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12
-$24.00K
derived: sum of 2 quarters · filed 2021-11-12
-$23.00K
10-Q · filed 2021-11-12
-$23.00K
derived: sum of 4 quarters · filed 2021-11-12
2020-06-30-$22.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12
-$21.00K
10-Q · filed 2021-08-12
-$21.00K
derived: sum of 3 quarters · filed 2021-08-12
$48.00K
derived: sum of 4 quarters · filed 2021-08-12
2020-03-31$1.00K
10-Q · filed 2021-05-10
$1.00K
derived: sum of 2 quarters · filed 2021-05-10
$70.00K
derived: sum of 3 quarters · filed 2021-05-10
2019-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-04
$69.00K
derived: sum of 2 quarters · filed 2021-03-04
$64.00K
10-K · filed 2021-03-04
-$37.00K
10-K · filed 2020-03-05
2019-09-30$69.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12
$64.00K
10-Q · filed 2020-11-12
-$37.00K
10-Q · filed 2019-11-06
2019-06-30-$5.00K
10-Q · filed 2020-08-14
-$37.00K
10-Q · filed 2019-08-08

Similar stocks

Stock NameCountryMarket CapPE Ratio
Emergent BioSolutions Inc. (EBS)United States$0.347B-2.43
ENANTA PHARMACEUTICALS INC (ENTA)United States$0.349B-6.72
Benitec Biopharma Inc. (BNTC)United States$0.337B-10.08
BioAge Labs, Inc. (BIOA)United States$0.333B-11.88
Vogenx, Inc. (VOGX)United States$0.355B
BridgeBio Oncology Therapeutics, Inc. (BBOT)United States$0.320B-3.35
Evommune, Inc. (EVMN)United States$0.320B-5.10
Prelude Therapeutics Inc (PRLD)United States$0.318B-7.01
ABEONA THERAPEUTICS INC. (ABEO)United States$0.312B-5.63
GT Biopharma, Inc. (GTBP)United States$0.309B-4.58